Close
CDMO Safety Testing 2026
Novotech

Clariant starts monthly production of 2 million liters of disinfectant in Gendorf to support vital institutions during COVID-19 outbreak

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Clariant, a focused and innovative specialty chemical company, announced it has started monthly production of 2 million liters of disinfectant at its facilities in Gendorf, Germany. This disinfectant is then directly or via repacking partners provided to regional hospitals and other vital institutions in Bavaria, who are currently facing limited availability of this critical product during the COVID-19 outbreak.

At its facility in Gendorf, Clariant is able to use its available infrastructure to blend the necessary ingredients into disinfectant at a large scale. This allows the company to fulfill close to two-thirds of the monthly target demand of the Bavarian State, which aims for a total of 10 million liters of disinfectants to be produced over the next three months. Costs associated with this program are financed by a crisis fund set up by the State of Bavaria, Clariant offered its contribution at cost price.

โ€œAt times like this, it is vital that everyone, be it individuals or companies, contributes in every way possible to reduce the spread of the virus. We at Clariant have the capability to support those working the hardest to protect all of us. Therefore, our employees acted decisively to ensure it was doneโ€, said Hans Bohnen, Chief Operating Officer of Clariant.

In order to realize the production of such large volumes of disinfectant, Clariant has cooperated with several other companies. The main ingredient, ethanol from renewable sources, was provided by CropEnergies AG. Their facility in Zeitz, Saxony-Anhalt, one of Europeโ€™s largest production sites for renewable ethanol, produces the ethanol and ships it to Clariant in Gendorf. For this process, support was given by several logistics and infrastructure partners. After inspection and approval, the ethanol is then mixed with other ingredients in Clariantโ€™s production facilities to produce disinfectant according to an official standard of the World Health Organization (WHO). Upon completion, the disinfectant is filled into large tank containers. Other partnering companies fill packaging in suitable sizes, ranging from 1 to 1,000 liters, after which the disinfectant is distributed to regional hospitals and other vital institutions.

Thanks to all these contributions, it was possible to support the Bavarian authorities and establish a stable supply chain for disinfectant on short notice and of large proportions. The total of 10 million liters would represent approximately 750 ml. of disinfectant for every resident of Bavaria.

Stephan Trautschold, Head of Operations for Clariantโ€™s Industrial and Consumer Specialties business, added: โ€œBeing able to establish production of such large quantities of disinfectant so quickly is an impressive achievement. I am very proud of our entire team at the Gendorf site, Clariantโ€™s service functions and very appreciative of the support from all other partnering companies and the Bavarian authorities. Together we can make a difference by supporting those in need.โ€

Clariant is a focused and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2019, the
company employed a total workforce of 17 223. In the financial year 2019, Clariant recorded sales of CHF 4.399 billion for its continuing
businesses. The company reports in three business areas: Care Chemicals, Catalysis and Natural Resources. Clariantโ€™s corporate strategy is
based on five pillars: focus on innovation and R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป